White-matter markers for psychosis in a prospective ultra-high-risk cohort

Psychological Medicine

Volumn 40, Issue 8, 2010, Pages 1297-1304

  Bloemen, O J N ^a   De Koning, M B ^a   Schmitz, N ^a   Nieman, D H ^a   Becker, H E ^a   De Haan, L ^a   Dingemans, P ^a   Linszen, D H ^a   Van Amelsvoort, T A M J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

DT MRI; FA; schizophrenia; transition; UHR; white matter

Indexed keywords

ADOLESCENT; ADULT; ANISOTROPY; ARTICLE; BRAIN; CHRONIC DISEASE; COHORT ANALYSIS; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; IMAGE PROCESSING; MALE; MYELINATED NERVE; PATHOLOGY; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; REFERENCE VALUE; RISK FACTOR; SCHIZOPHRENIA; SCHIZOTYPAL PERSONALITY DISORDER;

ADOLESCENT; ADULT; ANISOTROPY; BRAIN; CHRONIC DISEASE; COHORT STUDIES; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE PROGRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; NERVE FIBERS, MYELINATED; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; REFERENCE VALUES; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SCHIZOTYPAL PERSONALITY DISORDER; YOUNG ADULT;

EID: 77957142468     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291709991711     Document Type: Article

References (36)

1. Antonova E, Sharma T, Morris R, Kumari V (2004). The relationship between brain structure and neurocognition in schizophrenia: a selective review. Schizophrenia Research 70, 117-145.
2. Ashburner J, Friston KJ (2000). Voxel-based morphometry-the methods. Neuroimage 11, 805-821.
3. Ashburner J, Friston KJ (2001). Why voxel-based morphometry should be used. Neuroimage 14, 1238-1243.
4. Basser PJ (1995). Inferring microstructural features and the physiological state of tissues from diffusion-weighted images. NMR in Biomedicine 8, 333-344.
5. Basser PJ, Mattiello J, LeBihan D (1994). MR diffusion tensor spectroscopy and imaging. Biophysical Journal 66, 259-267.
6. Beaulieu C (2002). The basis of anisotropic water diffusion in the nervous system-a technical review. NMR in Biomedicine 15, 435-455.
7. Buchsbaum MS, Tang CY, Peled S, Gudbjartsson H, Lu D, Hazlett EA, Downhill J, Haznedar M, Fallon JH, Atlas SW (1998). MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia. Neuroreport 9, 425-430.
8. de Koning MB, Bloemen OJ, van Amelsvoort TA, Becker HE, Nieman DH, van der Gaag M, Linszen DH (2009). Early intervention in patients at ultra high risk of psychosis: benefits and risks. Acta Psychiatrica Scandinavica 119, 426-442.
9. Ellison-Wright I, Bullmore E (2009). Meta-analysis of diffusion tensor imaging studies in schizophrenia. Schizophrenia Research 108, 3-10.
10. Friedman JI, Tang C, Carpenter D, Buchsbaum M, Schmeidler J, Flanagan L, Golembo S, Kanellopoulou I, Ng J, Hof PR, Harvey PD, Tsopelas ND, Stewart D, Davis KL (2008). Diffusion tensor imaging findings in firstepisode and chronic schizophrenia patients. American Journal of Psychiatry 165, 1024-1032.
11. Hoptman MJ, Nierenberg J, Bertisch HC, Catalano D, Ardekani BA, Branch CA, Delisi LE (2008). A DTI study of white matter microstructure in individuals at high genetic risk for schizophrenia. Schizophrenia Research 106, 115-124.
12. Howes OD, Montgomery AJ, Asselin MC, Murray RM, Valli I, Tabraham P, Bramon-Bosch E, Valmaggia L, Johns L, Broome M, McGuire PK, Grasby PM (2009). Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Archives of General Psychiatry 66, 13-20.
13. Jones DK, Symms MR, Cercignani M, Howard RJ (2005). The effect of filter size on VBM analyses of DT-MRI data. Neuroimage 26, 546-554.
14. Kay SR, Fiszbein A, Opler LA (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13, 261-276.
15. Kircher TT, Liddle PF, Brammer MJ, Williams SC, Murray RM, McGuire PK (2001). Neural correlates of formal thought disorder in schizophrenia: preliminary findings from a functional magnetic resonance imaging study. Archives of General Psychiatry 58, 769-774.
16. Konrad A, Winterer G (2008). Disturbed structural connectivity in schizophrenia primary factor in pathology or epiphenomenon? Schizophrenia Bulletin 34, 72-92.
17. Lappin JM, Dazzan P, Morgan K, Morgan C, Chitnis X, Suckling J, Fearon P, Jones PB, Leff J, Murray RM, McGuire PK (2007). Duration of prodromal phase and severity of volumetric abnormalities in first-episode psychosis. British Journal of Psychiatry Supplement 51, s123-s127.
18. Miller TJ, McGlashan TH, Rosen JL, Cadenhead K, Cannon T, Ventura J, McFarlane W, Perkins DO, Pearlson GD, Woods SW (2003). Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophrenia Bulletin 29, 703-715.
19. Mori S, Wakana S, Nagae-Poetscher L, van Zijl P (2005). MRI Atlas of Human White Matter. Elsevier: Amsterdam.
20. Muñoz Maniega S, Lymer GK, Bastin ME, Marjoram D, Job DE, Moorhead TW, Owens DG, Johnstone EC, McIntosh AM, Lawrie SM (2008). A diffusion tensor MRI study of white matter integrity in subjects at high genetic risk of schizophrenia. Schizophrenia Research 106, 132-139.
21. Olsen KA, Rosenbaum B (2006). Prospective investigations of the prodromal state of schizophrenia: review of studies. Acta Psychiatrica Scandinavica 113, 247-272.
22. Peters BD, de Haan L, Dekker N, Blaas J, Becker HE, Dingemans PM, Akkerman EM, Majoie CB, van Amelsvoort T, den Heeten GJ, Linszen DH (2008). White matter fibertracking in first-episode schizophrenia, schizoaffective patients and subjects at ultra-high risk of psychosis. Neuropsychobiology 58, 19-28.
23. Peters BD, Schmitz N, Dingemans PM, van Amelsvoort TA, Linszen DH, de Haan L, Majoie CB, den Heeten GJ (2009). Preliminary evidence for reduced frontal white matter integrity in subjects at ultra-high-risk for psychosis. Schizophrenia Research 111, 192-193. Published online: 15 April 2009. doi: 10.1016/j.schres.2009.03.018.
24. Pierpaoli C, Basser PJ (1996). Toward a quantitative assessment of diffusion anisotropy. Magnetic Resonance in Medicine 36, 893-906.
25. Schmand B, Bakker D, Saan R, Louman J (1991). [The Dutch Reading Test for Adults: a measure of premorbid intelligence level]. Tijdschrift voor Gerontologie en Geriatrie 22, 15-19.
26. Shenton ME, Dickey CC, Frumin M, McCarley RW (2001). A review of MRI findings in schizophrenia. Schizophrenia Research 49, 1-52.
27. Spitzer RL, Williams JB, Gibbon M, First MB (1992). The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Archives of General Psychiatry 49, 624-629.
28. Talairach J, Tournoux P (1988). Co-planar Stereotaxic Atlas of the Human Brain. Thieme: New York.
29. Tamagaki C, Sedvall GC, Jonsson EG, Okugawa G, Hall H, Pauli S, Agartz I (2005). Altered white matter/gray matter proportions in the striatum of patients with schizophrenia: a volumetric MRI study. American Journal of Psychiatry 162, 2315-2321.
30. Walterfang M, McGuire PK, Yung AR, Phillips LJ, Velakoulis D, Wood SJ, Suckling J, Bullmore ET, Brewer W, Soulsby B, Desmond P, McGorry PD, Pantelis C (2008a). White matter volume changes in people who develop psychosis. British Journal of Psychiatry 193, 210-215.
31. Walterfang M, Yung A, Wood AG, Reutens DC, Phillips L, Wood SJ, Chen J, Velakoulis D, McGorry PD, Pantelis C (2008b). Corpus callosum shape alterations in individuals prior to the onset of psychosis. Schizophrenia Research 103, 1-10.
32. Whalley HC, Gountouna VE, Hall J, McIntosh A, Whyte MC, Simonotto E, Job DE, Owens DG, Johnstone EC, Lawrie SM (2007). Correlations between fMRI activation and individual psychotic symptoms in un-medicated subjects at high genetic risk of schizophrenia. BMC Psychiatry 7, 61.
33. WHO (1993). Composite International Diagnostic Interview-Version 1.1. World Health Organization: Geneva.
34. Witthaus H, Brune M, Kaufmann C, Bohner G, Ozgurdal S, Gudlowski Y, Heinz A, Klingebiel R, Juckel G (2008). White matter abnormalities in subjects at ultra high-risk for schizophrenia and first-episode schizophrenic patients. Schizophrenia Research 102, 141-149.
35. Woods SW (2003). Chlorpromazine equivalent doses for the newer atypical antipsychotics. Journal of Clinical Psychiatry 64, 663-667.
36. Yung AR, Phillips LJ, Yuen HP, Francey SM, McFarlane CA, Hallgren M, McGorry PD (2003). Psychosis prediction: 12-month follow up of a high-risk ('prodromal") group. Schizophrenia Research 60, 21-32.